Human Onchocerciasis: Modelling the Potential Long-term Consequences of a Vaccination Programme.
BACKGROUND:Currently, the predominant onchocerciasis control strategy in Africa is annual mass drug administration (MDA) with ivermectin. However, there is a consensus among the global health community, supported by mathematical modelling, that onchocerciasis in Africa will not be eliminated within...
Main Authors: | Hugo C Turner, Martin Walker, Sara Lustigman, David W Taylor, María-Gloria Basáñez |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC4506122?pdf=render |
Similar Items
-
Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.
by: Hugo C Turner, et al.
Published: (2013-01-01) -
The Onchocerciasis Vaccine for Africa--TOVA--Initiative.
by: Peter J Hotez, et al.
Published: (2015-01-01) -
Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control
by: Tekle Afework, et al.
Published: (2012-02-01) -
From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes.
by: Robert Colebunders, et al.
Published: (2019-07-01) -
Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection
by: Proaño Roberto, et al.
Published: (2007-05-01)